Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma ; volume:7 ; number:4 ; year:2020 ; pages:144-150
Gastrointestinal tumors ; 7, Heft 4 (2020), 144-150
- Creator
-
Badar, Wali
Van Ha, Thuong
Zangan, Steven
Navuluri, Rakesh
Pillai, Anjana
Baker, Talia
Ahmed, Osman
- DOI
-
10.1159/000508386
- URN
-
urn:nbn:de:101:1-2020101500203019326356
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Badar, Wali
- Van Ha, Thuong
- Zangan, Steven
- Navuluri, Rakesh
- Pillai, Anjana
- Baker, Talia
- Ahmed, Osman
Other Objects (12)
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Planning Arteriography for Yttrium-90 Microsphere Radioembolization
Gastroduodenal ulceration following liver radioembolization with yttrium-90
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Survival Benefit of Aggressive Treatment Approaches Incorporating Yttrium-90 Radioembolization for Late-Stage Hepatocellular Carcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma